235 related articles for article (PubMed ID: 25846450)
1. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
Shawcross DL
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):539-42. PubMed ID: 25846450
[TBL] [Abstract][Full Text] [Related]
2. The Link between Gut Microbiota and Hepatic Encephalopathy.
Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.
Zhu R; Liu L; Zhang G; Dong J; Ren Z; Li Z
Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37279097
[TBL] [Abstract][Full Text] [Related]
4. Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy
Luo M; Xin RJ; Hu FR; Yao L; Hu SJ; Bai FH
World J Gastroenterol; 2023 Jan; 29(1):144-156. PubMed ID: 36683714
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota: its role in hepatic encephalopathy.
Rai R; Saraswat VA; Dhiman RK
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and hepatic encephalopathy.
Coltart I; Tranah TH; Shawcross DL
Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
[TBL] [Abstract][Full Text] [Related]
7. Clinical science workshop: targeting the gut-liver-brain axis.
Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
[TBL] [Abstract][Full Text] [Related]
8. Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy.
Mancini A; Campagna F; Amodio P; Tuohy KM
Food Funct; 2018 Mar; 9(3):1373-1388. PubMed ID: 29485654
[TBL] [Abstract][Full Text] [Related]
9. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Complications of Liver Disease.
Acharya C; Bajaj JS
Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.
Liu J; Xu Y; Jiang B
Front Cell Infect Microbiol; 2021; 11():586427. PubMed ID: 33692964
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.
Garcovich M; Zocco MA; Roccarina D; Ponziani FR; Gasbarrini A
World J Gastroenterol; 2012 Dec; 18(46):6693-700. PubMed ID: 23239905
[TBL] [Abstract][Full Text] [Related]
13. The role of microbiota in hepatic encephalopathy.
Bajaj JS
Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
[TBL] [Abstract][Full Text] [Related]
14. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
[TBL] [Abstract][Full Text] [Related]
15. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of microbiome in patients with decompensated cirrhosis.
Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
[TBL] [Abstract][Full Text] [Related]
17. Microbiome: Emerging Concepts in Patients with Chronic Liver Disease.
Reuter B; Bajaj JS
Clin Liver Dis; 2020 Aug; 24(3):493-520. PubMed ID: 32620285
[TBL] [Abstract][Full Text] [Related]
18. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and hepatic encephalopathy.
Dhiman RK
Metab Brain Dis; 2013 Jun; 28(2):321-6. PubMed ID: 23463489
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatic encephalopathy in patients with cirrhosis.
Wright G; Jalan R
Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
